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Abstract 
 
Ischaemic preconditioning (IPC) is an intervention whereby brief intermittent ischaemic 
episodes are induced in a limb (usually 4x5-minute arterial occlusion bouts, interspersed with 
5-minutes of reperfusion) either at the site of interest (IPC), or at a distance from the site of 
interest (Remote; RIPC). Although originally linked to cardiology, recently studies have 
investigated the effects of IPC administered on a limb prior to exercise with some showing 
improvements in exercise performance. The overarching aim of the present thesis was to 
investigate how to optimise IPC to further enhance exercise performance. 
 
The optimal protocol of IPC on exercise performance was quantified by manipulating: 1. the 
number of cycles, 2. amount of muscle tissue, and 3. local vs Remote occlusion, which were 
applied in a randomized counterbalanced order in study 1 (Chapter 3). IPC dose, location and 
occlusion area differed prior to a 375 KJ time trial (TT) performance in 12 trained men. The 
traditional 4x5-min IPC stimulus resulted in the fastest TT time compared to SHAM [17 secs 
(90% CI: 0, 34 secs); P=0.097], but there was no benefit of applying a greater number of cycles 
[5 secs (-35, 26 secs); P=0.49] or employing unilateral IPC [18 secs (-11, 48 secs, P=0.29]. 
Local versus Remote cuff placement did not result in changes in TT time [0 secs (-16, 16 secs; 
P>0.9]. Overall, regardless of location, the 4x5-minute dose seemed to provide the most benefit 
to exercise performance. 
 
The ability of IPC to enhance exercise capacity may be mediated through altering exercise-
induced blood flow and/or vascular function. Study 2 (Chapter 4) investigated the blood flow 
response to exercise, using ultrasound, when exercise was preceded by a control (SHAM) 
condition, or either local or Remote (R)IPC in eighteen recreationally trained males. Vascular 
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function tests were also performed before SHAM and (R)IPC and at the end of exercise. IPC 
resulted in enlarged brachial artery diameter during exercise [0.016 cm (0.003 to 0.03 cm); 
P=0.016] compared to RIPC, but blood flow during exercise was similar between conditions. 
No changes in post-exercise vascular function were observed between conditions. Therefore, 
enhanced vasodilation following local (but not Remote) IPC, when performed prior to exercise, 
does not translate into increased blood flow during exercise nor impact post-exercise vascular 
function. 
 
IPC could alleviate deleterious muscle damage responses after exercise-induced muscle damage 
(EIMD; often lasting <72 hours). Study 3 (Chapter 5) investigated whether IPC could negate 
eccentric exercise-induced reductions in torque production. Eleven recreationally trained males 
completed 200 repetitions of maximal eccentric contractions when preceded by IPC or SHAM 
performed in a randomized order, separated by a 9-week washout period.  Muscle function tests 
were performed after IPC/SHAM prior to eccentric exercise and at 1-hour, 24-hours, 48-hours 
& 72-hours post-EIMD. Venous blood samples were taken at all time points. Greater maximal 
[15.2 N.m-1 (6.2 to 24.1); P=0.006] and mean [13.3 N.m-1 (5.3 to 21.3); P=0.007] torque 
production during a fixed angle voluntary maximal voluntary contraction (MVC) task and 
during a 60 deg·sec-1 [10.1 (4.9 to 15.3); P=0.002 & 9.8 N.m-1 (6.1 to 13.5; P<0.005] isokinetic 
task were evident after IPC versus SHAM prior to eccentric exercise (EIMD). This was 
maintained throughout the (72-hour) muscle damage window. Lower cytokine (IL-6 and IL-
1ra) were reported after IPC versus SHAM (P<0.002, respectively). IPC resulted in greater 
overall HSP-27 & 32 levels (P<0.01) whilst HSP-72 was lower (P=0.001) versus SHAM. 
Therefore, IPC can enhance maximal torque production during isokinetic dynamometry, before 
and after muscle damaging exercise and induce advantageous extracellular stress responses to 
EIMD in humans. 
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Study 4 employed IPC in a practical exercise-priming model, that aimed to maximise repeated 
sprint ability (RSA). Eleven trained cyclists performed 4 experimental visits in a repeated 
measures design. The “traditional” 4x5-minute local IPC (IPC) dose was compared to a SHAM 
condition (20 mmHg). IPC or SHAM were performed on two separate visits, each combined 
with either passive muscle heating (HEAT) on two visits, or thermoneutral (non-heated) 
insulation on two visits, prior to an “all out” repeated sprint task (10x6-second sprints with 24-
seconds of recovery). There were no meaningful changes in 10x6-second average [12 (-7 to 31) 
watts; P=0.28] or peak [6 (-14 to 26) watts; P=0.62] power output following IPC versus SHAM. 
Additionally, no benefit was observed when muscle temperature was elevated in combination 
with IPC [5 (-14 to 19) watts; P=0.67], or separately to IPC [9 (-9 to 28); P=0.4] versus SHAM. 
Overall, it appears that IPC, nor (the combination of) muscle heating can positively impact RSA 
performance in trained cyclists versus a SHAM condition. 
 
The findings from this thesis suggest that using a “traditional” dose of 4x5-minute cycles, either 
on the legs or the arms, promote performance enhancements in aerobic tasks such as cycling TT 
performance. These potential performance improvements are likely not resultant from increased 
limb blood flow. IPC can also enhance muscle function following muscle damaging exercise 
and induce advantageous extracellular stress responses to EIMD. Nevertheless, IPC alone or 
when combined with local muscle heating likely has no meaningful enhancements in repeated 
sprint cycling performance. The findings from this thesis may help athletes to establish a better 
understanding of how IPC can be used prior to exercise.  
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Chapter 1 
Introduction  
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Ischaemic preconditioning (IPC) is a method whereby brief intermittent ischaemic episodes are 
induced in a limb (usually 3 or 4x5-minute arterial occlusion bouts, interspersed with 5-minutes 
of reperfusion). It was the seminal findings from Murry et al. (Murry et al., 1986) that suggested 
multiple angina episodes preceding myocardial infarction in humans may protect against 
necrotic cell tissue death, allowing greater salvage of myocardium after ischaemia/reperfusion 
injury. Subsequently, Przyklenk et al. (Przyklenk et al., 1993) demonstrated that IPC could be 
applied from a distance (Remote (R)IPC) and yet induce a similar magnitude of tissue protection 
versus direct (local) application to a site of injury. These findings expanded the applicability of 
using IPC to human and animal limbs as a non-invasive tool. To date, this method has been used 
as a clinical tool in order to enhance a tissues tolerance to ischaemia-induced injury (Barrington 
et al., 2017). The positive findings in humans (Kharbanda et al., 2001; Kimura et al., 2007) 
finally lead to the first human exercise study being undertaken (de Groot et al., 2010), resulting 
in exciting and novel findings.  
Over the last eight years, a plethora of research studies (~40 studies) have aimed to determine 
the impact that IPC (remote and local) can exert in relation to exercise performance. Two 
systematic reviews (Incognito et al., 2016; Salvador et al., 2016) highlighted the potential for 
IPC to enhance endurance type events, but also reinforced the need to further investigate the 
effects of IPC prior to exercise performance.  More recently, practitioners and researchers have 
posed questions such as; “how does IPC exert its effects to enhance exercise capacity?” and 
“How should this be optimally used to help an athlete?” These questions are critical in 
determining if, how and when IPC should be used in an elite performance setting, with the sole 
aim of enhancing athletic performance.  
There are several important issues to address before some of these questions can be adequately 
answered. Firstly, “how should IPC be optimally used to help an athlete?”. Whilst it is suggested 
19 
 
that small improvements in aerobic exercise could be observed following IPC (Salvador et al., 
2016), numerous studies have failed to control or standardise how IPC is performed. This has 
lead to wide variations in protocol methodology that differ in: 1) the number of occlusion cycles, 
2) tissue occlusion area (unilateral or bilateral IPC) and 3) cuff location (local or Remote cuff 
placement). The influence of a “dose-dependent” IPC response has therefore been poorly 
controlled to date. Secondly, a relevant question relates to “how does IPC exert its effects to 
enhance exercise capacity?”. There are some studies suggesting IPC could mediate its beneficial 
effects via its impact on metabolic, sympathetic and/or cardiovascular systems (Bailey et al., 
2012; Bailey et al., 2012; Horiuchi et al., 2015; Kido et al., 2015). It is possible, based on 
previous research, that the ability of IPC to enhance exercise capacity may be mediated through 
altering exercise-induced blood flow and/or vascular function (Bailey et al., 2012; Enko et al., 
2011; Jones et al., 2014), but further research is required to understand this concept. These two 
questions will be directly assessed in the first studies. 
It is now well established that  tissue-protection is enhanced immediately after IPC (0-4 hours) 
and again in a delayed (12-72 hours) response (Hausenloy and Yellon, 2010). There has been 
limited investigation into the effects of delayed preconditioning on exercise performance 
(Seeger et al., 2016). Nevertheless, this bi-phasic IPC-induced tissue protection against injury, 
suggest that IPC could protect skeletal muscle injury in response to exercise-induced muscle 
damage (EIMD), a condition often lasting up to 72 hours after eccentric exercise. Therefore, a 
third research question is whether IPC can be used to attenuate muscle injury after muscle 
damaging exercise, offering indirect avenues to promote optimal performance (or to prevent 
decrements in exercise performance typically experienced after muscle damaging exercise). 
Finally, from an athlete/coach perspective, exercise priming strategies, such as IPC, will 
potentially be employed if found to exert small but meaningful effects on performance. The 
20 
 
commonly implemented recovery time between IPC and commencement of the exercise is often 
20-30-minutes (Salvador et al., 2016) which provides an opportunity to try and embed IPC 
within an optimised exercise priming strategy (Faulkner et al., 2013a; Kilduff et al., 2013a). 
Therefore, a final aspect worth consideration is “can IPC be combined with other priming 
strategies to further potentiate the impact of standard priming strategies to exercise 
performance?”. One commonly utilised priming strategy is increasing muscle temperature, or 
maintaining muscle temperature after a warm-up with external heating devices/garments 
(Faulkner et al., 2013a). The mechanisms by which IPC and elevated muscle temperature 
enhance exercise performance likely differ. Therefore, together they could be additive, if 
combined prior to an appropriate exercise task. 
Aims and objectives: 
The overarching aim of present thesis is to investigate how to optimise IPC for further enhancing 
exercise performance. Based on the available research evidence and important considerations 
of using IPC to enhance exercise performance, the specific study aims are: 
1.  To examine whether the (i) number IPC cycles (i.e. “dose-cycles”), (ii) the amount of muscle 
mass occluded (“dose-tissue”), and (iii) the application of IPC to either local or Remote limbs 
(“Remote”) affect the potency of IPC to improve endurance cycling performance in trained 
cyclists. 
2. To examine the impact of IPC and Remote IPC on exercise-mediated changes in artery 
diameter and blood flow in healthy young individuals.  
3. To investigate whether IPC enhances muscle strength (i.e. torque production) following 
EIMD in recreationally trained humans.  
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4. To compare IPC and passive local muscle heat maintenance, or a combination of both 
interventions, on repeated sprint ability exercise (RSA) performance in trained cyclists. 
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Chapter 2 
Review of the Literature 
 
The text originally presented here cannot be made freely available via LJMU E-Theses 
Collection because of copyright reasons. The text was sourced at 
https://www.elsevier.com/books/the-science-of-hormesis-in-health-and-longevity/rattan/978-
0-12-814253-0 - (See Appendix 1). 
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Chapter 3 
The effect of IPC dose on endurance cycling performance 
 
 
 
The text originally presented here cannot be made freely available via LJMU E-Theses 
Collection because of copyright reasons. The text was sourced at 
https://journals.humankinetics.com/doi/abs/10.1123/ijspp.20170114?rfr_dat=cr_pub%3Dpub
med&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=ijspp - (See 
Appendix 2). 
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Chapter 4 
The effect of Remote vs Local IPC on blood flow response 
 
 
The text originally presented here cannot be made freely available via LJMU E-Theses 
Collection because of copyright reasons. The text was sourced at 
https://www.frontiersin.org/articles/10.3389/fphys.2018.00435/full - (See Appendix 3). 
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Chapter 5 
The effect of Ischaemic Preconditioning on Muscle Torque 
and Systemic Stress Responses to Exercise-Induced Muscle 
Damage 
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5.1 Introduction 
 
Skeletal muscle damage can be described as the loss of function, usually occurring from either 
a metabolic- or mechanical-induced stress, resulting in the disruption of muscle structures that 
are responsible for force production (Newham et al., 1983). Mechanical stress-induced muscle 
damage is usually a consequence of undertaking either unfamiliar- or eccentric-exercise tasks 
(Brooks et al., 1995).  Acute eccentric work often results in exercise-induced muscle damage 
(EIMD), typically inducing significant losses in functional capacity and increased pain 
perception during movements and tasks performed 24-72 hours post-exercise (Howatson and 
Van Someren, 2008), alongside a greater rate of tension per active fiber (Newham et al., 1983). 
Accordingly, impaired post-exercise recovery from EIMD may have deleterious impacts on 
athletic performance during this 24-72 hour EIMD window (Smith, 1992).  
EIMD is likely to impact athletes that compete in tournament situations (e.g. team sports), 
specifically the ability to generate force or power repeatedly (Bishop and Girard, 2013), where 
time between competitive bouts may be insufficient to ameliorate EIMD responses. This 
highlights the importance of strategies to prevent or attenuate EIMD. One study, investigated 
the impact of IPC on eccentric exercise and found bilateral arm IPC prior to a bicep curl 
eccentric exercise task (3 x 10 repetitions at 80% 1 repetition maximum)  reduced CK responses, 
lowered pain responses and maintained muscle function over a 72-hour period versus a SHAM 
condition (Franz et al., 2017a). Whilst muscle function was assessed via use of radial 
displacement, no maximal performance tasks were performed. Currently, how IPC influences 
maximal contraction exercise performance in exercise-induced damaged muscle can only be 
speculated and this question remains poorly understood. Moreover, limb cuff occlusions applied 
after muscle damaging exercise (post-exercise intermittent blood flow occlusion bouts) 
enhanced recovery of muscle damage responses in both isokinetic dynamometry (Page et al., 
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2017) and countermovement jump performance (Beaven et al., 2012). Taken together, it is 
possible IPC could enhance the capacity to generate muscle torque following EIMD, but no 
study to date has aimed to assess performance responses in humans. Additionally, whether IPC 
enhances recovery kinetics (<72 hours) of maximal torque production following EIMD remains 
to be established. 
During EIMD various cellular processes are activated and expressed to modulate or mitigate 
deleterious responses to damage, including cytokines such as Interleukin-6 (IL-6) and 
Interleukin 1 receptor agonist (IL-1ra) (de Oliveira et al., 2011; Nieman et al., 2005). In 
addition, heat shock proteins (HSPs) are conserved ubiquitous stress proteins that carry out 
highly varied functions (Noble et al., 2008), with previous studies suggesting that HSP-72 and 
HSP-32 are involved in the associated resistance to hypoxic stress, ischaemia-reperfusion injury 
and likely EIMD (Barrington et al., 2017; Stagos et al., 2015; Taylor et al., 2012). HSP-72 
targets denatured proteins (Taylor et al., 2012), likely promoting refolding of sub-lethally 
damaged proteins (Marber et al., 1993), whilst HSP-32 may be important to restore ROS-
producing heme-molecule degradation under conditions of low oxygen availability (Gozzelino 
et al., 2010; Taylor et al., 2012) and EIMD (Stagos et al., 2015). Small HSP’s (HSP-27) have 
previously been shown to not respond to non-damaging endurance exercise in the muscle 
(Morton et al., 2008), but HSP-27 translocation may help to limit cytoskeletal damage following 
EIMD (Koh and Escobedo, 2004). Given their involvement in EIMD, the potential effects of 
IPC on EIMD may be effectively modulated through the systemic cytokine and HSP-response 
to EIMD in humans. 
The primary aim of the current study was to investigate whether IPC could enhance maximal 
torque production pre- and post- EIMD in humans which is yet to be assessed in the literature. 
To better understand the potential underlying mechanisms how IPC may influence functional 
28 
 
responses to EIMD, a secondary aim was to evaluate whether IPC mediated favourable systemic 
cytokine (IL-6 and IL1ra) and HSP stress responses (HSP-72, -32, -27). It was hypothesized 
that IPC would enhance torque recovery, whilst simultaneously alleviating extracellular stress 
responses to EIMD via reducing systemic cytokine responses and altering HSP levels before 
and after EIMD when compared to a SHAM condition. 
 
5.2 Methods 
 
5.2.1 Location of testing and Ethical Approval 
All experimental protocols and data collection procedures were undertaken in the research 
testing laboratory of the Athlete Health and Performance laboratory, situated inside Aspetar 
Sports Medicine Hospital, Doha. All studies included in this thesis were presented to, and 
approved by both the local chief medical officer scientific committee and the local ethics 
committee (Anti Doping Laboratory Qatar; ADLQ). Ethical approval number for this study was 
F2017000229. 
5.2.2 Inclusion/exclusion criteria 
Participants provided written informed consent. Physical activity readiness questionnaires 
(PAR-Q) were administered to ensure no participant had any health implications that would 
prevent participation in the study. All participants were male, between the ages of 18-40 years 
with no history of operations on the lower limbs and injury free for the previous 6 months. They 
were regularly training prior to the study to ensure no period of detraining occurred. Participants 
were excluded if they had any health contraindications, as determined by the PAR-Q or if they 
were regularly undertaking resistance exercise. All individuals refrained from exercise and 
alcohol consumption 24 hours, and consumption of caffeine at least 12 hours, respectively, prior 
to the first laboratory visit. 
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5.2.3 Participants 
Eleven recreationally active males undertaking regular endurance training or team sport 
competition (mean±SD: age, 33.1±5.3 years; body mass, 78.3±8.3 cm; height 181±7 cm; 
Resting Blood Pressure, 123±8 / 72±8 mmHg; Resting Heart Rate, 60±8 beats.min-1) were 
recruited. Participants provided written informed consent. 
5.2.4 Familiarisation Testing 
Resting blood pressure was obtained from participants 5-minutes after arrival (Vital Signs 
Monitor SP-800, G-Care Electronics Ltd. United Kingdom). Participants were then seated on 
the isokinetic dynamometer (IsoForce, TUR GmbH, Berlin, Germany) and the dominant leg 
was securely strapped to the Isokinetic dynamometer lever arm. The lateral femoral condyle 
was aligned with the dynamometer arm axis of rotation and the knee angle was set to 60 degrees 
from extension (anatomical zero). The femoral nerve was electrically stimulated during the 
contraction (voltage 400 V, rectangular pulse of 0.2 ms) via a high-voltage stimulator (Digitimer 
DS7AH, Digitimer, Hertfordshire, UK) through a cathode placed distally to the inguinal fold 
and an anode placed laterally to the gluteal fold. The stimulation intensity was adjusted for each 
individual participant by progressively increasing amperage (starting at 10-miliampere [mA]) 
by 10-mA increments until a plateau in twitch mechanical response was achieved (peak twitch; 
PT). The stimulation intensity during Twich-MVC was calculated by multiplying the minimum 
electrical intensity required to elicit the PT by 1.5. Once established, participants performed a 
5-second MVC. A superimposed doublet stimulation was administered once a plateau in MVC 
was achieved. Subsequently, a potentiated twitch was evoked 4 s after the MVC, respectively, 
using doublet stimulation at 100 Hz. Data collected from the force transducer during 
contractions was subsequently analysed using AcKnowledge v.3.7.2 software (BIOPAC 
systems inc. Santa Barbara, CA, USA). With the aim of enhancing MVC inter-trial reliability 
(Shield and Zhou, 2004), at least 2 familiarisation trials were undertaken prior to the first 
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experimental visit in order to ensure muscular performance was reliable. Data from 
familiarisation sessions revealed a mean familiarisation MVC value of 274±47 N.m-1, with a 
mean intra-individual coefficient of variation (CoV) of 3.84±3.86 % for peak torque (N.m-1). 
The same equipment, positions, and procedures were used between trials and the isokinetic 
dynamometer was calibrated to the manufactures guidelines before each test session. 
5.2.5 Design 
Participants reported to the laboratory and performed either IPC or SHAM in a randomised, 
counterbalanced order, using a crossover study design (Figure 5.1). For each condition, 
participants undertook a minimum of two familiarisation sessions, separated by a minimum of 
24 hours, to ensure that they were familiar with the muscle function test protocol and maximal 
force was consistent between visits (< 10%) (Owens et al., 2015). On the first experimental 
visit, participants lay in a supine position and received either 4x5-minutes of IPC or SHAM, 
totaling 40-minutes. Participants performed a standardised warm-up before undertaking the 
baseline (pre-ECC (eccentrics)) muscle function test protocol (consisting of 1 x MVC (maximal 
voluntary contraction) [superimposed twitch technique; Twitch-MVC], 1 x voluntary MVC 
[without stimulation; MVC-2], 1 x isokinetic task at 60 deg·sec-1 [IKD-60] and 1 x isokinetic 
task at 120 deg·sec-1 [IKD-120]) all of which were performed on the dominant leg. Following 
this a unilateral leg eccentric-exercise (200 repetitions) protocol commenced on the dominant 
leg, with the intention of inducing muscle damage (EIMD). The muscle function test battery 
(MVCs and IKDs) was then repeated 1-hour post-EIMD (post-1), 24-hours post-EIMD (post-
24), 48-hours post-EIMD (post-48) and 72-hours post-EIMD (post-72). Venous blood samples 
were obtained prior to IPC or SHAM, immediately post-IPC/-SHAM, then at the same time 
points as the muscle function assessments. Participants were instructed to refrain from exercise 
24 hours prior to the experimental visit and for the duration of trial (i.e. between baseline and 
post-72). They then underwent a 9-week washout period to limit the impact of the repeated bout  
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effect, and were instructed to return to, and maintain their normal physical activity routines, whilst not conducting heavy lower leg resistance training. 
 
Figure 5. 1. Protocol schematic detailing experimental laboratory visit order of events.  
 
5.2.6 IPC protocols 
For both the IPC and SHAM trials, a 13.5 cm wide cuff were placed bilaterally on the most proximal portions of the upper thighs. Participants lay 
in a supine position and cuff inflation pressure was standardised at 220 mmHg for the IPC condition and 20 mmHg in the SHAM condition, 
respectively. Cuff pressures were attained with the use of an automatic rapid cuff inflator (Hokanson, Washington, USA). Pressure during IPC (220 
mmHg) and SHAM (20 mmHg) was held for a duration of 5-minutes, interspersed with 5-minutes of complete deflation (0 mmHg). 
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5.2.7 Muscle Function Test Protocols: 
To quantify torque production in laboratory settings, isokinetic dynamometry and fixed angle 
maximal voluntary contraction protocols are commonly employed (Owens et al., 2015). Whilst 
not entirely specific to competition, these tasks can provide mechanistic inference to 
performance and show moderate correlations with certain performance markers in athletes 
(Saliba and Hrysomallis, 2001). Participants were seated with the knee angle positioned at 60° 
from extension (anatomical zero) and the dominant leg was securely strapped to the Isokinetic 
dynamometer lever arm. Pre-twitch (PT) torque was measured using a singlet stimulation at the 
intensity determined from familiarization testing. After a standardised warm-up (50% MVC x 
10 repetitions, 75% MVC x 3 repetitions, 1 x near maximal (<1 second) repetition), participants 
waited 1-minute before producing a 5-second MVC effort (Twitch-MVC). To elicit Twitch-
MVC, a doublet stimulation at 100 Hz was administered (approx. 3 secs into the contraction) 
once a plateau in MVC was achieved. A post-contraction potentiated twitch was evoked approx. 
3-secs after relaxation, using a doublet stimulation at 100 Hz. Data collected from the force 
transducer [Pre-Twitch (PT) torque; defined as singlet pre-warm up stimulation, maximal torque 
(maximal torque); defined as peak voluntary torque attained, percentage maximal involuntary 
activation (% activation); defined as the % of voluntary activation from doublet stimulation 
torque value, and post-contraction potentiated stimulation torque (Post-stim); defined as torque 
attained from the post-contraction doublet stimulation] during contractions were subsequently 
analysed using AcKnowledge v.3.7.2 software (BIOPAC systems inc. Santa Barbara, CA, 
USA). Criteria to reject a maximal voluntary contraction was: 1. the force trace exhibited no 
clear plateau prior to the superimposed stimulation; 2. the superimposed stimulation was 
delivered when voluntary force was not at or close to its maximum for that contraction; 3. the 
participant perceived that their effort was submaximal at the time of stimulation (Shield and 
Zhou, 2004). Following a 3-minute recovery from Twitch-MVC, an additional voluntary MVC 
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(MVC-2) was performed, without stimulation to elicit maximal voluntary contraction responses. 
Following Twitch-MVC and MVC-2 tests, two isokinetic tasks were performed; each test 
separated by 3-minutes of rest. The isokinetic test protocol consisted of four maximal 
contractions at two different fixed movement velocities. Firstly, 1.05 rad·sec-1 (60 deg·sec-1 
[IKD-60]) and secondly at 2.09 rad·sec-1 (120 deg·sec-1 [IKD-120]). Mean (the average torque 
value for each contraction) and peak (the maximal torque value during contraction) torque (N.m-
1) was calculated for each repetition, and the varying rate of contractions were separated by a 3-
minute recovery period. 
5.2.8 Eccentric Exercise Protocols: 
Participants were strapped to the isokinetic dynamometer, with the dominant leg attached to the 
dynamometer arm. They then performed 20 sets of 10 maximal repetitions at a constant speed 
of 30 deg·sec-1, equating to a total of 200 eccentric contractions (Owens et al., 2015b). Each set 
was interspersed with a 30-second recovery interval. Between repetitions, the isokinetic 
dynamometer arm was passively raised at a speed of 30 deg·sec-1 prior to the participant 
commencing the subsequent contraction. Participants were instructed to produce a maximal 
effort for each repetition performed. Range of motion was standardised between blocks to 
ensure contraction length did not vary and total work done (kJ) was recorded for analysis. 
5.2.9 Exercise Discomfort – Delayed Onset of Muscle Soreness (DOMS) ratings: 
A VAS scale (0-10) was used to determine perceived discomfort during sets 1-10 and sets 11-
20 of eccentric-exercise (ECC). The same VAS scale was used to monitor the magnitude of 
delayed onset of muscle soreness (DOMS) ratings for each of the 5 MVC function tests, with 0 
being no DOMS, and 10 being worst possible DOMS. 
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5.2.10 Venous Blood Sampling: 
For the assessment of biochemical stress markers, venous blood samples (8 mL) were drawn 
from an antecubital vein, with use of an elasticated tourniquet (Latex free tourniquet, BD 
vacutainerTM systems, NJ, USA)). The tourniquet was deliberately applied for <1 minute to 
avoid localised haemoconcentration to prevent calculation of erroneous serum data (Nikolac et 
al., 2013). Samples were collected at rest in supine position. Serum was collected using 2 x 
SSTTM 13 x 100 mm (4 mL volume) blood collection tubes (BD Vacutainer®, Becton, Dickson 
and Company, Oakville, Ontario) containing spray-coated silica and polymer gel for serum 
separation. Venous samples were taken at seven separate time points for each experimental 
condition (Prior to IPC or SHAM (Pre-IPC), immediately post-IPC or SHAM, immediately 
(Post-IPC), immediately post eccentrics (Post-ECC-0), 1-h post eccentrics (Post-1), 24-h post 
eccentrics (Post-24), 48-h post eccentrics (Post-48) and 72-h post eccentrics (Post-72). Blood 
samples were centrifuged ~90-minutes after collection in a swinging bucket rotor of the 
Multifuge® 1S/1S-R for 10-minutes at 3000-rpm at a temperature of 24 degrees Celsius. The 
resulting serum was then manually pipetted (Eppendorf, Hamburg, Germany) into Eppendorf 
low bind protein tubes (Eppendorf, Hamburg, Germany). Eppendorf tubes were then stored at -
80 degrees Celsius in a laboratory freezer (Thermo Fisher Scientific, (Asheville) LLC, NC, 
USA). 
5.2.11 Enzyme-Linked Immunosorbent Assay: 
Heat shock 27kDa protein (HSP-27) (ng/ml), HSP-32kDa (HSP-32) (ng/ml), HSP-72kDa (HSP-
72) (ng/ml), interleukin 1 receptor antagonist (IL-1ra) (pg/ml) and interleukin 6 (IL-6) (pg/ml) 
concentrations were determined using commercial kits (Cloud-Clone Corp., Texas, USA). The 
limits of sensitivity were ≤0.31 ng/ml, ≤0.119 ng/ml, ≤0.6 ng/ml and ≤3.3 pg/ml, respectively. 
The mean intra-assay coefficient of variation (CV) reported for these parameters were <10%. 
An automatic enzyme linked immunosorbent assay (ELISA) microplate reader (Infinite® 200 
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PRO NanoQuant, Switzerland) and Magellan Standard software (version 7.1) were used. A 
Sunrise microplate absorbance reader (Tecan, Grödig, Austria), and Magellan Standard software 
(version 7.1, Tecan Group Ltd. Männedorf, Switzerland) were used to analyse samples. 
5.2.12 Statistical Analysis: 
When assessing torque responses to muscle damage the primary outcome variable is torque 
production (N.m-1) for each exercise task. Maximal torque (N.m-1) for MVC superimposed and 
MVC (without stimulation) and both mean and maximal torque (N.m-1) for IKD-60 and IKD-
120 tasks were analysed using repeated measures general linear modelling ((Condition [2 
levels]: IPC vs SHAM) x (Time Point [5 levels]: Pre-ECC, Post-1, Post-24, Post-48, Post-72)). 
Secondary outcome measures were analysed using repeated measures general linear modelling 
((Condition [2 levels]: IPC vs SHAM) x (Time Point [7 levels]: Pre-IPC, Post-IPC, Post-0, Post-
1, Post-24, Post-48, Post-72)). The least significant difference (LSD) method was employed for 
pairwise comparisons (Perneger, 1998). The level of significance (alpha) was set at P=0.05. 
Any P value that was reported as “0.00” in SPSS was reported as “P<0.005)”. 
 
5.3 Results 
 
5.3.1 Eccentric Exercise 
The total work done (kJ) during each eccentric exercise bout was comparable between SHAM 
and IPC (main effect of condition: P=0.22). Rate of perceived exertion and perceived 
discomfort throughout the IPC and SHAM 20-sets of eccentric exercise were also not different 
(P>0.05; Table 5.1). The DOMS ratings at the various post-exercise time-points increased 
following eccentric exercise, with peak DOMS score at the post 48-hr time point [3.6 (2.9, 4.2) 
/ 10 VAS score; Table 5.2] when compared with all other time-points (P<0.05, respectively). 
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There was no main effect of condition nor condition x time interaction in DOMS ratings 
(P>0.05, Table 5.2). 
Table 5. 1. Data representing physical and perceptual ratings during eccentric exercise bouts 
between conditions. RPE derived from Borg (6-20) scale whilst perceived discomfort derived 
from VAS scale (0-10). 
 
Table 5. 2. Summary of the Delayed Onset of Muscle Soreness (DOMS) scores prior to each 
muscle function test. Scores derived from VAS scale (0-10). 
 
5.3.2 Twitch-MVC 
There was a main effect of time for all variables, with a reduction from pre-ECC to post-damage 
time points in PT torque (P<0.005), maximal torque (P<0.005) and post-stim (P<0.005; Table 
3). No main effect of condition was observed in PT torque, maximal torque, % activation or 
post-stim (P>0.05, respectively) (Table 5.3). No effect of time was observed for % activation 
(P=0.28). There was no evidence of condition x time interactions for any Twitch-MVC 
(P>0.05, respectively).
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Table 5. 3. Twitch-MVC variables for both IPC and SHAM throughout various time-points 
  Pre-ECC Post-1 Post-24 Post-48 Post-72   
  IPC SHAM IPC SHAM IPC SHAM IPC SHAM IPC SHAM P value 
PT (N.m-1) 33.8±4.9 33.7±5 23.9±6 24.1±7.6 34.7±5 32.8±6.2 39.5±6.8 34.7±9.5 38.6±7.3 36.8±5.5 0.5 
 
Maximal 
torque (N.m-1) 268.6±39.3 266.8±53.8 214±32.7 215.2±48.6 240.4±50.9 239.1±53.5 242.3±50.5 230.1±54 255.1±64.5 238.5±52.3 0.98 
 
% activation (% 
of max) 98.3±12.5 94.9±15.2 94.1±27.7 94.2±19.3 92.2±8.8 92.9±17.4 93.8±10.8 94±19.2 96.9±17.8 86.4±17.1 0.4 
 
Post-stim 
(N.m-1) 100.9±19.9 88.5±20.1 78.5±18.3 74.3±15.4 88±14.1 90±10.3 92.3±18.1 91.4±15.9 100.2±21.5 93.3±16.6 0.23 
 
 
5.3.3 MVC-2 (without stimulation) 
There was a main effect of time for both maximal and mean torque (P<0.005), with both reducing by 50.3±8 and 47±11 N.m-1 at post-1 and then 
gradually returned to pre-ECC levels at each time point (post-24 to post-72). IPC was associated with a significantly higher maximal torque of 15.2 
N.m-1 (6.2, 24.1; P=0.006) and mean torque of 13.3 N.m-1 (5.3, 21.3; P=0.007) compared to SHAM (Figure 5.2). There was no evidence of a 
condition x time interaction (P>0.05). 
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Figure 5. 2. Mean (A) and maximal (C) torque displayed for MVC-2 (without stimulation) 
responses to EIMD after IPC or SHAM treatments. Absolute Torque production values 
displayed on the left, with relative changes compared to pre-ECC in mean (B) and maximal (D) 
Torque values displayed on the right. * represents statistically significant differences between 
condition 
 
5.3.4 Isokinetic tasks (60 & 120 deg·sec-1) 
Maximal and mean torque decreased by similar magnitudes at post-1 for both IKD-60 (37.6 & 
26.8 N.m-1, respectively) and IKD-120 (35.3 & 27.6 N.m-1). Maximal and mean torque for both 
tasks gradually returned to pre-ECC levels at each subsequent time point (post-24 to post-72, 
main effect of time P<0.05, respectively). During IKD-60, IPC was associated with a higher 
maximal torque of 10.1 N.m-1 (4.9, 15.3; P=0.002) and mean torque of 9.8 N.m-1 (6.1, 13.5; 
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P<0.005) compared to SHAM (Figure 5.3). No significant improvements were reported for 
maximal or mean torque in the IKD-120 task (P>0.05). There was no evidence of a condition x 
time interaction (P>0.05). 
 
Figure 5. 3. Mean (A) and maximal (C) torque displayed for IKD-60 responses to EIMD after 
IPC or SHAM treatments. Absolute Torque production values displayed on the left, with relative 
changes compared to pre-ECC in mean (B) and maximal (D) Torque values displayed on the 
right. * represents statistically significant differences between condition 
 
5.3.5 Cytokine Responses (pg/mL) 
A main effect of time was observed for serum IL-1ra (P<0.005) but not serum IL-6 (P=0.37; 
Figure 5.4). Serum IL-1ra [-7.9 (-12.3, -3.4) pg/mL; P=0.001] and IL-6 [-0.39 (-0.63, -0.15) 
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pg/mL; P=0.002] were lower following IPC versus SHAM. There was no condition x time 
interaction for IL-1ra or IL-6 (P>0.05, respectively; Figure 5.4). 
 
Figure 5. 4. Extracellular serum IL-6 (A) and IL-1ra (B) cytokine response (pg/mL) at individual 
time points in IPC and SHAM conditions. * represents significantly lower serum cytokine levels 
between conditions. 
 
5.3.6 Heat Shock Proteins (ng/mL) 
There was a condition x time interaction in HSP-27 and HSP-32 (P<0.02, respectively).  IPC 
resulted in greater serum levels of HSP-27 [1.01 (0.55, 1.47) ng/mL; P<0.005] with 
significantly greater serum HSP-27 [3.01 (1.96, 4.06) ng/mL; P<0.005] levels at post-IPC 
compared to SHAM (Figure 5.5). HSP-32 was also greater following IPC versus SHAM [0.13 
(0.03, 0.23) ng/mL; main effect of condition: P=0.01] with significant increases in HSP-32 
observed Post-ECC-0 [0.32 (0.05, 0.57) ng/mL; P=0.02], post-1 [0.38 (0.1, 0.63) ng/mL; 
P=0.005] and at post-24 [0.37 (0.1, 0.63) ng/mL; P=0.007] time points (figure 5.5). A main 
effect of condition was observed for HSP-72 (P=0.001), with lower serum HSP-72 observed in 
IPC versus SHAM (P<0.005). Reductions in HSP-72 were observed at pre-IPC in IPC versus 
SHAM (-0.44 (-0.81, -0.07; P=0.02; figure 5.5) but HSP-72 was not different between 
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conditions at the post-IPC time point. Following eccentric exercise, HSP-72 was similar 
between conditions. Beyond this time-point, the gradual reduction in HSP-72 in IPC resulted in 
significantly lower values versus SHAM at post-48 and post-72 time points (P=0.007 & 
P=0.004, respectively). There was a main effect of time for HSP-27, HSP-72 and HSP-32 
(P<0.003, respectively).  No condition x time interaction effect was observed for HSP-72 
(P>0.05). 
 
Figure 5. 5. Extracellular serum HSP-32 (ng/mL) (A), HSP-27 (ng/mL) (B) and HSP-72 
(ng/mL) (C) responses at individual time points in IPC and SHAM conditions. * represents 
statistically significant main effect of condition. # represents a condition x time interaction effect 
of IPC versus SHAM. 
 
5.4 Discussion 
The aim of this study was to investigate whether IPC could enhance muscle torque production 
(i.e. a measure of muscle function) following EIMD in humans and whether IPC mediated its 
effect on EIMD via a reduction in systemic cytokine and HSP stress responses. The following 
findings were evident. First, fixed angle voluntary MVC was enhanced at pre-ECC following 
IPC and this effect was maintained throughout the EIMD (0-72 hours) window versus SHAM. 
Second, performance of the slower (60 degrees.sec-1) dynamic contraction task was enhanced 
at pre-ECC following IPC compared to SHAM, an effect that was also present up to 72h post 
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EIMD. These effects were not present during the faster (120 deg.sec-1) dynamic contraction 
task. Third, reductions in extracellular cytokine responses to EIMD were observed, alongside 
alterations in HSP responses after IPC, when compared to SHAM. Taken together, these data 
provide preliminary evidence that IPC enhances torque production following EIMD, and this 
increase in skeletal muscle function, coincides with changes in both cytokine and HSP 
responses.  
5.4.1 Muscle Function Responses 
The current study, to the author’s knowledge is the first study in humans to show that IPC 
enhances muscle torque production during maximal fixed angle and slower (60 degrees.sec-1) 
velocity dynamic contractions, before and after exposure to EIMD, when compared to a SHAM 
condition. It has been shown previously, using an animal model, that IPC can have a positive 
impact on skeletal muscle function, assessed by a 6-second maximal electrical stimulation task, 
in response to damage caused by 60 min of  limb ischaemia (Phillips et al., 1997) and these 
finding broadly support this data. The capacity for IPC to enhance muscle torque production 
prior to eccentric exercise in the current study also corroborate previous findings demonstrating 
IPC improved 5-repetition maximal isokinetic dynamometry when compared to SHAM in non-
damaged muscle (Paradis-Deschênes et al., 2016). Presently, explanation as to why IPC did not 
have a notable impact on the faster dynamic task (120 deg.sec-1) is unclear. The speed of 
movement during isokinetic tasks may induce differential functional responses on the muscle. 
Slower dynamic movement velocities (i.e. 60 deg·sec-1) are more appropriate to elicit peak 
torque (Baltzopoulos and Brodie, 1989), and may further prevent limb blood flow (Paradis- 
Deschênes et al. 2016), and increase intramuscular pressures (Saltin et al., 1998) compared to 
faster velocity exercise tasks. Regardless, current findings suggest IPC has an overall beneficial 
response on muscle torque production pre- and post-EIMD in humans. 
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IPC can induce tissue protection during specific timing windows (Hausenloy and Yellon, 2010; 
Pang et al., 1995). The timing of IPC administration may influence EIMD responses. IPC has 
been shown to induce immediate protection against ischaemic insult in skeletal muscle (Pang et 
al., 1995), whereby 3x10 minute ischaemia/reperfusion cycles resulted in preferential 
maintenance of muscle metabolites following 4 hours of ischaemic insult in latissimus-dorsi 
muscle. This response was maintained following 1.5 hours of reperfusion (Pang et al., 1995). 
Within the current study, all muscle function tests on the first experimental visit (day 1) were 
performed within this immediate (< 4 hour) protective window. Further tissue-protection can 
also be evident during a secondary protective timing window termed the second window of 
protection (SWOP) (Hausenloy and Yellon, 2010). Muscle function tests at 24-, 48- and 72-
hours post eccentric exercise in the current study, coincided with the second window of 
protection (SWOP), and again, greater torque values were observed in this window.  
5.4.2 Extracellular Cytokine Responses 
Current study findings show reductions in both IL-6 and IL-1ra immediately after IPC (pre-
ECC), which remained lower compared to SHAM after the exercise bout, possibly implying a 
blunted pro-inflammatory activity after eccentric exercise. IL-6 is thought to be an important 
mediator in the repair process following injury through its ability to inhibit expression of other 
pro-inflammatory cytokines such as IL-1 and TNF-alpha (TNF-α) (Chamberlain et al., 2013).  
IL-6 may exert greater influence on anti-inflammatory cytokines following EIMD, compared 
with IL-1ra (Peake et al., 2005), however, IL-6 can promote expression of IL-1ra, a receptor 
agonist that directly antagonizes pro-inflammatory cytokine responses via binding to IL-1 
receptors (Chamberlain et al., 2013). The extracellular reduction in both IL-1ra and IL-6 
markers after IPC versus SHAM suggests a lower pro-inflammatory response to eccentric 
exercise when preceded by IPC.  
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5.4.3 HSP responses 
Induction of HSP-27 is likely a contributing factor in cellular protection afforded prior to 
prolonged ischemic insult in the myocardium (Das et al., 1993), whilst translocation of small 
HSP’s (HSP-25 & HSP-27) is specific to damaging (eccentric) contractions in animals (Koh 
and Escobedo, 2004). The results of the current study imply an enhanced HSP-27 response 
directly after IPC (pre-ECC); a finding consistent with previous work demonstrating enhanced 
HSP-27 mRNA after IPC in myocardium (Das et al., 1993) and extracellular increases in HSP-
27 release following global ischaemia (Jin et al., 2014).  Whether greater extracellular HSP-27 
after IPC afforded greater tissue-protection against eccentric exercise in the current study is 
unknown. Regardless, this finding may represent one of many humoral responses that can 
potentially afford tissue protection against cellular damage.  
HSP-32 is often expressed in conditions of oxidative challenge. This HSP is also described as 
Heme-oxygenase-1 (HO-1) and has been described as a distal mediator of delayed 
preconditioning in cardiomyocytes (Hausenloy and Yellon, 2010) whereby increased levels of 
HO-1 are observed during the SWOP after IPC (Jancso et al., 2007). The current data show 
EIMD induced a reduction in HSP-32 in SHAM, but not in IPC, as IPC appeared to maintain 
HSP-32 levels. These findings may indicate that IPC provided greater anti-oxidant reserve status 
following EIMD versus SHAM (Stagos et al., 2015), however anti-oxidant reserve status was 
not directly measured. Future work may help to elicit more detailed information surrounding 
this postulated mechanism.  
In contrast to HSP-32, reductions in specific HSPs is purportedly due to a lower pro-oxidant 
state (Fehrenbach et al., 2000) and in contrast to its intracellular molecular chaperone role, 
extracellular HSP-72 acts as a potent cytokine, stimulating pro-inflammatory mediators after 
incurring stressful stimuli (Asea et al., 2000).  The overall main effect of lower extracellular 
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HSP-72 in IPC versus SHAM conditions may have been partly influenced from lower pre-IPC 
(baseline) HSP-72 in the IPC condition. Nevertheless, HSP-72 immediately increased following 
after application of IPC, to match SHAM levels. Gradually, HSP-72 reduced following EIMD 
in the IPC condition and significant differences were observed at post-48 and post-72-time 
points. In the current study, the extracellular elevations in HSP-27 and HSP-32, but not HSP-72 
after EIMD, may suggest IPC blunts the systemic stress response to a bout of eccentric exercise.  
5.4.4 Limitations 
All cytokine and HSP analyses were performed on extracellular serum concentrations. The roles 
of extracellular vs intracellular stress responses vary greatly, so the current data should be 
interpreted with caution.  Another limitation is that cytokines or HSP responses are affected by 
the magnitude of oxidative stress incurred following EIMD, a variable known to vary between 
individuals (Stagos et al., 2015). However, the crossover design of this study, in combination 
with the 9-week washout, controlled for inter-individual variation in cytokine and HSP 
responses. Therefore, it is likely that this does not impact the main study findings. To date, there 
is no consensus on the wash out period needed to abolish the repeated bout effect. The repeated 
bout effect is characterized by a blunted damage response to eccentric exercise when a previous 
eccentric exercise bout has been performed. There are suggestions that the repeated bout effect 
can persist up to 6-months after EIMD (Nosaka et al., 1991). Importantly, the order of testing 
blocks (IPC/SHAM) was randomized. Previous data shows serum stress biomarker and 
perceived muscle soreness responses to EIMD are suppressed at 3- and 6-weeks post-exercise 
(Byrnes et al., 1985; Nosaka et al., 1991), therefore a 9-week washout period was employed in 
the current study. Previous work has demonstrated significant muscle damage responses after 
the exact protocol used in the current study (Owens et al., 2015b) and, the reduction in both 
DOMS ratings and muscle torque were similar to values reported elsewhere (Stagos et al., 
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2015). Based on the above, it is likely that sufficient muscle damage was induced prior to 
measurement of both muscle function and extracellular stress responses. 
5.4.5 Conclusion 
The findings of the current study suggest that IPC enhances torque production in non-damaged 
muscle versus SHAM. EIMD resulted in similar decrements in muscle torque in both IPC and 
SHAM conditions, however, IPC maintained greater torque production capability throughout 
the (<72 hr) EIMD window alongside favourable changes in cytokine and HSP responses. These 
findings may suggest IPC can elicit favorable damage responses in recreationally trained 
humans that experience EIMD.  
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Chapter 6 
A comparison of ischaemic preconditioning and muscle heat 
maintenance as exercise priming strategies 
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6.1 Introduction 
Priming/preconditioning methods, administered prior to performance, aiming to augment or 
potentiate high-intensity exercise performance are now common practice in elite sport (Beaven 
et al., 2018). Most athletes will aim to sufficiently warm-up before competition, but certain 
priming strategies may magnify the benefits of warm-ups, including ischaemic preconditioning 
(IPC) (Patterson et al., 2015), and muscle and/or core temperature manipulation (Beaven et al., 
2018; Kilduff et al., 2013b). 
Ischaemic preconditioning, administered at an appropriate time prior to exercise performance 
has previously been shown to enhance both aerobic (Bailey et al., 2012; Crisafulli et al., 2011; 
Kido et al., 2015) and anaerobic (Cruz et al., 2016; Paradis-Deschênes et al., 2016; Patterson et 
al., 2015) exercice performance. The proposed mechanisms contributing to performance 
enhancements include enhanced ?̇?O2 kinetics (Kido et al., 2015), greater muscle oxygenation 
and perfusion (Paradis-Deschênes et al., 2016) and enhanced neuromuscular responses to 
exercise (Cruz et al., 2015). Therefore, IPC could be an effective strategy to improve exercise 
performance that is dependent on both anaerobic and aerobic capacity, such as repeated sprint 
ability. 
Performance improvements have also been observed when muscle temperature is elevated prior 
to exercise performance. Specifically, sprint-based exercise can benefit from higher muscle 
temperature at the beginning of exercise (Beaven et al., 2018; Faulkner et al., 2013a; Kilduff et 
al., 2013b). Increased muscle temperature is thought to improve performance via a range of 
mechanisms, such as, enhanced muscular function at the onset of maximal exercise (Ferguson 
et al., 2002) and improved muscle contraction velocity capacity and rate of force development 
(Racinais and Oksa, 2010; Ranatunga, 1982).  
Taken together, both IPC and local muscle heating strategies can have a significant impact on 
sprint-type exercise, but the mechanisms mediating these performance improvements are likely 
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different. IPC, unlike localised muscle heating has also shown benefit to aerobic-type 
performance in humans (Salvador et al., 2016). Therefore, combining the 
priming/preconditioning strategies may be additive to RSA performance, especially as RSA 
tasks are  highly taxing of both aerobic and anaerobic energy systems (Girard et al., 2011). The 
primary aim of this study was to examine whether IPC, passive local muscle maintenance, or a 
combination of both strategies during warm-up improves repeated sprint ability (RSA) cycling 
performance. The secondary aim of this study was to relate any changes in performance (power 
output) with muscle oxygenation and muscle activation responses in trained cyclists. 
 
6.2 Methods 
 
6.2.1 Location of testing and Ethical Approval 
All experimental protocols and data collection procedures were undertaken in the research 
testing laboratory of the Athlete Health and Performance laboratory, situated inside Aspetar 
Sports Medicine Hospital, Doha. All studies included in this thesis were presented to and 
approved by both the local chief medical officer scientific committee and the local ethics 
committee (Anti-Doping Laboratory Qatar; ADLQ). Ethical approval number for this study was 
F2017000217. 
6.2.2 Inclusion/exclusion criteria 
Physical Activity Readiness Questionnaires (PAR-Q) were administered to ensure no 
participant had no contraindication that would prevent participation. Participants were included 
in the study if they were a competitive cyclist that had sprint training experience and had a 
?̇?O2max above 50ml·kg·min-1. Participants were excluded if they answered “yes” to any PAR-Q 
question, or if they had recent history of an injury that lead to a detraining period of more than 
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1-week. Exercise was prohibited 48 hours prior to testing, whilst caffeine and alcohol were 
restricted at least 6 and 24 hours prior to laboratory testing, respectively. 
6.2.3 Participants 
Eleven trained males (mean±SD: age, 33.7±4.8 years; body mass, 81.1±10 kg; height 181±7 
cm; ?̇?O2max, 57.4±5.0 ml·kg·min-1) undertaking regular high intensity interval cycling training 
(1-2 sessions per week) were recruited. Mean training experience was 9±8 years and mean 
weekly cycling training volume was 7±3 hours. 
6.2.4 Research Design 
The study compared four preconditioning strategies, as displayed in figure 6.1. Prior to 
commencement of four Repeated Sprint Ability (RSA) cycling tests. A practical pre-
competition model was employed that included 4 different preconditioning strategies; (1) IPC 
and thermoneutral (T-N) lower body insulation (IPC), (2) IPC and passive muscle heating of  
the lower limbs (IPC+HEAT), (3) SHAM and T-N lower body insulation (SHAM) and (4) 
SHAM and passive muscle heating of the lower limbs (HEAT). The four preconditioning 
strategies were administered in a randomized counterbalanced order. 
6.2.5 Experimental Protocol 
Prior to experimental visits, all participants completed familiarisation sessions and a maximal 
graded cycling test to establish ?̇?O2max and watt max (Wmax). During the experimental visits, 
participants entered the laboratory and firstly performed either ischaemic preconditioning (IPC) 
or a control (SHAM). Immediately following IPC or SHAM, in thermoneutral (T-N) conditions, 
insulation (elasticated tubigrips) was administered on the lower limb musculature. In heated 
(heated) conditions, 16 x heated pads (secured with elasticated tubigrips) were placed on the 
lower limb musculature and participants rested for 20-minutes. A 19-minute standardised 
cycling warm-up was then performed whilst wearing the insulation on the lower limbs. The 
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warm-up protocol aimed to elevate muscle temperature to above 39 degrees Celsius (°C) in both 
the T-N and heated conditions (see figure 6.2). After the cycling warm up participants rested for 
a further 12 minutes with the lower limb insulation still attached (either T-N or heated). During 
this period electromyography (EMG) electrodes (x3) and near-infrared spectroscopy (x1) probes 
were placed on the left and right leg, respectively. At minute 14 post-warm up, participants 
remounted the cycle ergometer and began pedaling at approximately 75 watts (W), aiming to 
reach a cadence of 105 revolutions per minute (RPM) within 1-minute. At minute 15 post-warm 
up, a 10x6-second repeated sprint task commenced. All participants were instructed to elicit 
peak power for the entire duration of each 6-second effort. Sprints were repeated 10 times 
interspersed with 24-seconds of recovery (9 seconds stationary recovery; 15 seconds spinning 
at 75 W). The primary performance outcomes were peak and average power output. Sprint-by-
sprint muscular activation and muscle oxygenation properties were secondary measures. 
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Figure 6. 1. Schematic of experimental protocol detailing the order of events on each laboratory 
visit 
 
6.2.6 Preliminary assessments 
6.2.6.1 Assessment of maximal oxygen uptake (𝑉 ̇O2max) 
At least 7 days prior to the first familiarisation session, participants performed a continuous 
incremental step test on a cycle ergometer (SRM, Julich, Germany) to determine maximal 
oxygen uptake (?̇?O2max). The protocol consisted of 3-minute stages and commenced at a power 
output of 95 W. An increase in 35 W per step occurred until volitional exhaustion was attained. 
Throughout the incremental test, breath-by-breath expired gases were monitored for oxygen 
consumption, ventilation and respiratory exchange ratio (Oxycon Pro ™, Carefusion, Germany) 
and the highest 30-second average, determined from 3 consecutive 10-second bins was taken to 
determine ?̇?O2max. Heart rate was also monitored continuously (Polar HI, Kempele, Finland). 
Maximal power output (Wmax) was calculated from the last completed workload, plus the 
fraction of time spent in the final non-completed stage multiplied by the work rate increment 
(Jeukendrup et al., 1996). 
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6.2.6.2 Familiarisation. 
At least 2 familiarisation trials of 10x6-second all-out sprints, separated by 24 seconds of 
recovery, were undertaken prior to experimental visits. This determined the natural variation in 
participant performance. Further familiarisation sessions were implemented if necessary. Data 
from familiarisation testing revealed coefficient of variations of 2.5±1.7 % & 3.1±1.5 % for 
mean and peak session power over the 10x6-second repeated sprints, respectively. 
6.2.7 Experimental Visits 
6.2.7.1 IPC protocols. 
For both the IPC and SHAM preconditioning strategies, a 13.5 cm wide cuffs were placed 
bilaterally on the most proximal portions of the upper thighs. Participants lay in a supine position 
and cuff inflation pressure was standardised at 220 mmHg for the IPC condition and 20 mmHg 
in the SHAM condition, respectively. Occlusion was attained with use of an automatic rapid 
cuff inflator (Hokanson, Washington, USA). Occlusion occurred for a duration of 5-minutes, 
interspersed with 5-minutes of complete deflation (0 mmHg). This process was repeated 4 times 
in total. 
6.2.7.2 Skin Temperature. 
Immediately following IPC or SHAM, a skin temperature sensor/data logger (iButtonTM, Maxim 
Integrated Products, Sunnyvale, CA USA) was activated and time synchronized prior to being 
placed on the upper right thigh. Skin temperature was continuously recorded throughout the 
duration of the experimental visits. Skin temperature data was downloaded at a sampling rate of 
60 (1 sample per minute) and exported to CSV file. Data was analysed at seven specific time 
points (1: Start warm up, 2: Warm up 5-min, 3: Warm up 10-min, 4: Warm up 15-min, 5: Finish 
warm up (Warm up 19-min), 6: Start Sprint & 7: Finish Sprint).  
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6.2.7.3 Lower Limb Insulation. 
After placement of the skin temperature button, lower limb insulation was placed on the lower 
limbs. In heated (HEAT and IPC+HEAT) conditions, sixteen (8 pads per limb) air activated 
adhesive muscle heat pads (THE HEAT COMPANY GmbH, Altenmarkt, Austria), reaching 
approx. 43°C in temperature were placed on the lower (VM, VL, RF, Gastroc, Soleus) limbs 
and secured with elasticated tubigrips (12cm Tubular support bandage, Bastos Viegas, s.a. 
Guilhufe, Penafiel-Portugal). For T-N (IPC and SHAM) conditions, no muscle heat pads were 
used, instead, elasticated tubigrips were placed directly on the skin. 
6.2.7.4 Cycling Warm-Up 
The warm-up was conducted on a cycle ergometer (SRM, Julich, Germany) lasting 19 minutes, 
10 seconds in total. The Wmax value attained from the incremental test was used to prescribe 3 
submaximal warm up stage intensities. These stages consisted of 5-minutes at 40, 50 & 60% 
Wmax respectively. At minute 15 of the warm up, participants increased cadence to 105 RPM, 
and at 15:30, began a progressive sprint warm up task consisting of 2 x 5 second efforts @ 50% 
peak power, 2 x 5 second efforts @ 75% peak power & 2 x 5 second efforts @ 100% peak 
power. The 50%, 75% and 100% 5-second efforts were separated by 10, 30 and 60 seconds of 
rest, respectively. Heart rate was monitored throughout the warm up (Polar H1, Kemple, 
Finland). 
Validation of Muscle Temperature Maintenance: 
To ensure the cycling warm up elicited a sufficient increase in muscle temperature in T-N and 
heated conditions, intramuscular muscle temperature was recorded via indwelling muscle 
temperature probes in two participants (Figure 6.2) prior to commencement of the study. One 
leg was heated with heat pads, while the other leg replicated T-N conditions. Muscle temperature 
was recorded during a simulated warm-up exercise bout and then monitored during the 15-
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minute recovery period. On a separate day to validating muscle temperature, skin temperature 
was also monitored. After 30-minutes of heat pad application on a single leg, skin temperature 
was continuously monitored for 5.5 hours on both heated, and non-heated legs. Mean skin 
temperature value for the heated leg was 41.2±0.8 °C versus 32.7±1 °C for the non-heated leg. 
 
Figure 6. 2. Muscle temperature assessments used to validate the warm-up protocol prior to 
experimental testing. (A) Located at 2/3 of Vastus lateralis from anterior superior iliac spine to 
lateral patella (B) the canula was aligned with the fiber pennation angle (C) and inserted prior 
to (D) inserting a muscle temperature probe at a depth of 2.5cm. Finally (E) after this procedure 
was repeated on both legs, participants mounted the bike with one heated quadricep (2 x muscle 
heat pads) and one T-N (non-heated) leg and began the warm up. Muscle temperature of each 
leg was recorded at set time points and is detailed below. 
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Figure 6. 3. Muscle temperature (depth at 2cm) data collected to prior to experimental trials, to 
validate the muscle heat maintenance protocol during and after the cycling warm-up. Data were 
collected throughout warm-up and 1-15-minutes post warm up. Muscle temperature at the end 
of the warm-up equaled 39.4±0.1 °C in heated leg and 39.2±0.3 °C in control leg (N=2). 
 
6.2.7.5 Muscle Heat Maintenance 
As soon as the warm up was completed, participants dismounted the bike and returned to a 
supine resting position for a total of 14-minutes, with either the application of muscle heat pads, 
or T-N insulation. 
6.2.7.6 Near Infrared Spectroscopy 
Changes in muscle oxygenation during the RSA test was determined using a wireless, 
continuous-wave near infrared spectroscopy (NIRS) system (Portamon; Artinis Medical 
Systems, BV, The Netherlands). The Portamon simultaneously uses the modified Beer-Lambert 
and spatially-resolved spectroscopy methods to determine changes in oxygenated haemoglobin 
(∆O2Hb) and de-oxygenated haemoglobin (∆HHb), expressed in micromolar units (µM). Due 
to spectral similarities, the contribution of myoglobin to the NIRS signal cannot be differentiated 
but is believed to be minimal (Ferrari et al., 2004; Mancini et al., 1994). This system also 
provides a measure of O2Hb saturation indicated by the tissue oxygenation index [TOI (%)], 
which reflects the dynamic balance between O2 demand and supply within the muscle 
microcirculation (McCully and Hamaoka, 2000). The Portamon unit consisted of three emitter 
diodes positioned 30, 35, and 40 mm from the detector, and emitted infrared light at wavelengths 
of 760 and 850 nm. All analyses were undertaken on data gathered from the 35 mm emitter-
detector distance, corresponding to a NIRS signal penetration depth of approximately 17.5 mm 
(Ferrari et al., 2011; McCully and Hamaoka, 2000). The Portamon unit was secured on the right 
limb vastus lateralis (VL) muscle using black adhesive tape (Kinesio Co., Ltd, Tokyo) 
reinforced with elasticated Tubigrip to prevent movement and signal contamination from 
57 
 
external light sources. The probe site was standardised for accurate re-positioning; at 2/3 of the 
distance from the anterior superior iliac spine (ASIS) to the lateral patella. The area of 
investigation was lightly shaved with a safety razor (Double Edge shaving Comb razor, National 
Medical Products Co. Ltd. KSA) and cleaned with a disposable sterile isopropyl alcohol swab 
(China Meheco Co, Ltd) prior to probe placement. All NIRS data were collected at 10 Hz using 
a dedicated software (Oxysoft, Artinis Medical Systems) and down sampled to 1 Hz for further 
analyses. Finally, a differential pathlength factor of 4 was implemented to account for scattering 
of light signal. A description of the analysis procedure is provided in figure 6.4. 
6.2.7.7 NIRS Data Analysis 
Typical changes in TOI during repeated sprint cycling are presented in Figure 6.7 of results 
section. A rapid decrease in TOI (i.e., muscle de-oxygenation) was observed following the onset 
of sprinting. During rest intervals, the recovery in TOI was preceded by a time delay (TD), 
which was the corresponding time (s) between the end of the sprint and the lowest 1-s TOI value 
before sustained re-oxygenation was observed (refer to shaded region in Figure 6.4). Muscle 
deoxygenation amplitude (DeoxyAMP) was determined by the change in TOI during each sprint 
(i.e., TOImax – TOImin), where TOImax and TOImin refer to the maximum and minimum TOI 
values at the onset, and at the end of each sprint, respectively (refer to figure 6.4). Similarly, re-
oxygenation amplitude (ReoxyAMP) was determined by the change in TOI during recovery 
(recTOImax – recTOImin), where recTOImin and recTOImax refer to the lowest and highest TOI 
values within the 10-s recovery period following the sprint. Muscle de-oxygenation and re-
oxygenation rates (following TD) were determined via simple regression as previously 
described (Ihsan et al., 2013): TOI=a × t + b, where a is the slope (%·s-1), t is the time (s) and b 
is the y-intercept (%). The slope (a) of the linear model fit was retained as the index of muscle 
de-oxygenation (Deoxyslope) or re-oxygenation (Reoxyslope) rates (figure 6.4). Linear modelling 
and analysis using minimum and maximum values demonstrates the best reliability for muscle 
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de-oxygenation and re-oxygenation rates (Ihsan et al., 2013), with previously reported 
coefficients of variation for DeoxySLOPE, ReoxySLOPE and TD of 7.2%, 21.4% and 8.1%, 
respectively (Ihsan et al., 2013). 
 
Figure 6. 4. Example of a single 6-second sprint, followed by a 24-second recovery. Assessment 
of NIRS data during sprints were obtained from the first 7 seconds of effort, accounting for any 
additional pedal strokes. Deoxygenation amplitude (DeoxyAMP) and slope (Deoxyslope) were 
calculated from the maximal (TOImax) and minimal (TOImin) values (black horizontal lines). 
Time Delay (TD) was defined as the time (in seconds) from post-sprint to the beginning of 
muscle reoxygenation. Recovery amplitude (ReoxyAMP) and rate (Reoxyslope) were calculated 
from maximal (recTOImax) and minimal (recTOImin) values (grey horizontal lines). 
 
6.2.7.8 Electromyography. 
Skin was prepared during the rest interval after warm-up cessation (see “Near Infrared 
Spectroscopy” methods section) and site positioning was standardised for each of the three 
muscles of interest (Rectus Femoris: 50% from ASIS to patella border; Vastus Lateralis: 2/3 
distance from ASIS to lateral patella; Biceps Femoris: 50% from ischial tuberosity to lateral 
patella). Electromyography was used to record and analyse myoelectric signals during sprint 
activity, whilst one electrode was placed on the cycle ergometer crank and used as an 
accelerometer. Electrodes were secured using black adhesive tape (Kinesio Co., Ltd, Tokyo) 
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and were reinforced with elasticated Tubigrip on the upper limb to prevent unit movement and 
signal contamination. All data were recorded at 2000 Hz using a Delsys Trigno Wireless System 
(Boston, MA), rectified and low-pass filtered with a Butterworth third-order low-pass zero-lag 
filter and a cut-off frequency of 20 Hz. To assess relative muscle activation across the different 
sprints, the EMG signal was normalized to its respective maximal contraction value obtained 
during the 10 sprints for each participant and condition and the respective peak amplitude 
calculated. To account for slight variation in placement between experimental visits and signal 
variance, a root mean squared (RMS) value, which reflects the mean power of the EMG signal, 
recommended for smoothing EMG data, was calculated for each sprint effort to derive muscle 
activation. The maximum RMS value for each muscle group was classified as 100%, all other 
RMS values were normalized to this value (% of maximum RMS). 
6.2.7.9 Repeated Sprint Ability Test 
During the repeated sprint protocol, the cycle ergometer (SRM, Julich, Germany) was set to 
isokinetic mode, whereby cadence was clamped at 105 RPM. Participants were instructed to 
build cadence to 105 RPM in the first minute, prior to commencing sprint 1. Participants 
completed 10 maximal sprint efforts in total, with each sprint lasting 6-seconds in duration with 
24-seconds of passive recovery in between. They were instructed to produce ‘all out’ effort from 
time point 0 until the end of the sprint. Participants began building cadence 15 seconds prior to 
each sprint to ensure cadence was at 105 RPM for the start of each repetition. 
6.2.7.10 Power Output Calculations 
Sprint power output was determined by analyzing SRM ergometer sprint files via custom 
training software (Golden Cheetah, version 3.3). Files were selected, and a custom interval 
search was conducted to find the 10 highest 6-second power output bouts for each test. Average 
and peak power output values were recorded for each sprint.   
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6.2.8 Statistical Analysis 
Using a magnitude-based inference framework, the mean effect of each sprint comparison was 
presented for the primary outcomes, with uncertainty of the estimates presented as 90% 
confidence intervals (appropriate SI units for a given variable). The mean difference between 
each comparison were evaluated for their practical significance by pre-specifying the smallest 
worthwhile change (SWC) (Batterham and Hopkins, 2006). For session average power output, 
and session peak power output, the SWC was calculated using 0.3 x coefficient of variation 
from familiarisation data (Hopkins et al., 2009), which equated to 6 and 9 watts, respectively. 
The noise to signal ratio was determined by calculating the typical error (TE; the SD of between-
trial differences divided by √2). The TE for peak and mean power output was 16 and 20 watts, 
respectively. Between each comparison, together with its uncertainty, the probability (percent 
chances) that the true population effect was beneficial (>SWC), harmful (>SWC with opposite 
sign), or trivial (within±SWC) was calculated (see section 3.2.7 for details). 
In combination with running magnitude-based inference statistics, the peak power and average 
(6-second) power output for each sprint, in addition to NIRS and EMG data for each sprint were 
analysed using a repeated measures 2-way general linear model (Condition [4 levels: IPC vs 
IPC + HEAT vs SHAM vs HEAT], Time [10 levels]: comparison of sprints 1-10) with 95% 
confidence intervals. The least significant (LSD) method was employed for pairwise 
comparisons (Perneger, 1998). All data were checked for normal distribution prior to statistical 
analysis, using the Shapiro-Wilk test.  
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6.3 Results 
6.3.1 Average & Peak Power Output 
IPC resulted in a 12 watts improvement (90% CI: -7, 31 watts) in average power output versus 
SHAM, which was greater than the SWC (6 watts) but lower than the calculated typical error 
(16 watts) and therefore was deemed an “unclear” change (Figure 6.5). HEAT versus SHAM [9 
watts (90% CI: -9, 28)] and IPC versus IPC+HEAT [7 watts (90% CI: -11, 26)] also resulted in 
changes greater than the calculated SWC but again were lower than the calculated typical error 
so were reported as “unclear” (Figure 6.5). There was a significant decrease over time in both 
6-second and peak power output (P<0.005, respectively). The mean reduction in 6-second 
power output from sprint 1 to 8 was 42±23 watts and the mean reduction in peak power from 
sprint 1 to 7 was 40±8 watts (P<0.006, respectively). Both 6-second power and peak power 
output plateaued at sprint number 9 and 8, respectively (P>0.05, respectively). There was no 
effect of condition on either 6-second power (P=0.64) or peak power output (P=0.98) (Figure 
6.6) across the 10 sprints and no condition x time interaction effect was observed for either peak 
(P=0.67) or 6-second (P=0.3) power output.  
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Figure 6. 5. Average power output during 10x6-second all out sprints between conditions (A), 
accompanied with likelihood of “beneficial”, “trivial” or “unlikely” performance outcome to 
10x6-second average power output (B). 
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Figure 6. 6. Peak power output during 10x6-second all out sprints between conditions (A), 
accompanied with likelihood of “beneficial”, “trivial” or “unlikely” performance outcome to 
10x6-second peak power output (B). 
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6.3.2 Muscle Deoxygenation 
There was a significant reduction over time (P<0.005, respectively) in DeoxyAMP (%) and 
Deoxyslope (% · second -1) with sprint 1 resulting in the largest DeoxyAMP and Deoxyslope when 
compared to all other sprints (P<0.03 & P<0.006, respectively). There was no overall main 
effect of condition for either DeoxyAMP (P=0.11) or Deoxyslope (P=0.08). However, a trend for 
greater DeoxyAMP after both HEAT and IPC+HEAT may have been present versus SHAM [4.5 
(-0.9, 9.8) % & 4.8 (-0.7, 10.3) %; P=0.1 & P=0.08, respectively]. SHAM resulted in a lower 
mean Deoxyslope compared to both IPC+HEAT [0.77 (-0.001, 1.54); P=0.05] and HEAT [0.76 
(-0.1, 1.63); P=0.08] conditions. No condition x time interaction effect was reported for either 
DeoxyAMP or Deoxyslope (P>0.05, respectively). 
 
 
Figure 6. 7. Typical NIRS muscle oxygenation data during 10x6-second all out sprints. TOI; 
Tissue oxygenation index, S1-10; Sprint number. 
 
6.3.3 Muscle Reoxygenation 
There was no main effect observed for time for either ReoxyAMP (%) (P=0.08) or Reoxyslope (% 
· second -1) (P=0.47). No main effect for condition was observed for ReoxyAMP (P=0.18 or 
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Reoxyslope (P=0.19), respectively. IPC+HEAT showed a trend for greater (2.2 to 2.4 %) 
increases in ReoxyAMP compared to HEAT, IPC and SHAM preconditioning strategies (P=0.09, 
P=0.19 & P=0.07, respectively; Table 6.1), whilst IPC+HEAT also showed a statistical trend 
for greater Reoxyslope compared with SHAM (0.5 % · second -1; P=0.05). No condition x time 
interaction was observed for either ReoxyAMP or Reoxyslope (P>0.05, respectively). 
 
 
 
Table 6. 1. Muscle deoxygenation [DeoxyAMP (%) & Deoxyslope (% · second -1)] and 
reoxygenation [ReoxyAMP (%) and Reoxyslope (% · second -1)] characteristics for 10 x 6-
second repeated sprints 
 
 
DeoxyAMP Deoxyslope ReoxyAMP Reoxyslope 
IPC 15 ± 7 3 ± 1 8 ± 2 1.1 ± 1 
HEAT 18 ± 8 3 ± 1 8 ± 3 1.4 ± 1 
IPC+HEAT 19 ± 9 3 ± 1 11 ± 5 1.5 ± 1 
SHAM 13 ± 4 2 ± 1 8 ± 3 1 ± 0 
 
6.3.4 EMG RMS (%) 
No time (P=0.17), condition (P=0.55), or condition x time interaction (P=0.57) effect was 
observed for VL RMS. For both RF and BF, a significant reduction in RMS was observed over 
time (P=0.02 & P<0.005, respectively). There was no main effect of condition for either RF 
(P=0.9) or BF (P=0.87). Finally, no interaction effect was observed for either RF or BF (P=0.74 
& P=0.67, respectively; Table 6.2). 
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Table 6. 2. RMS% values for VL, RF, and BF during 10x6-second repeated sprints 
 
 
6.3.5 Skin Temperature 
Skin temperature between preconditioning strategies was significantly different between 
HEATED and T-N preconditioning strategies (Figure 6.8). 
 
 
Figure 6. 8. Graphical representation of skin temperature during HEAT (38.4±1.9 °C), IPC 
(31.2±1.1 °C), IPC+HEAT (38.6±1.2 °C) and SHAM (31.1±1 °C).  
 
  HEAT IPC IPC+HEAT SHAM 
VL RMS% 85 ± 3 78 ± 3 82 ± 3 84 ± 3 
RF RMS% 80 ± 4 80 ± 2 78 ± 5 78 ± 4 
BF RMS% 75 ± 4 76 ± 6 74 ± 4 75 ± 5 
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6.4 Discussion 
The primary aim of this study was to compare IPC and passive local muscle heating or a 
combination of both preconditioning strategies on RSA performance. Specifically, this study 
explored, for the first time, whether a 4x5-minute local IPC strategy in combination with local 
muscle heat maintenance following a standardised cycling warm-up could enhance RSA 
capacity. In contrast to our hypothesis, RSA performance was not enhanced by either IPC, local 
muscle heating, or a combination of both strategies when compared to a control (SHAM) 
condition.  
6.4.1 Effects of IPC 
In contrast to the original hypothesis, study findings showed no effect of IPC alone on power 
output during 10x6-second RSA cycling. Whilst early research suggested IPC did not alter RSA 
(5x6-second sprints off 24-second recovery) performance in team sport athletes (Gibson et al., 
2013), more recent work reported benefits of IPC on power output during a RSA cycling task 
(Patterson et al. 2015). In that study the peak power improvements occurred during the first 3 
sprints versus SHAM suggesting IPC had a positive impact on anaerobic energy provision 
(Spencer et al., 2005). 
IPC has been proposed to elicit improvements in both anaerobic (Paradis-Deschênes et al., 
2016) and aerobic metabolism (de Groot et al., 2010). Although this exercise task is highly 
anaerobic, the aerobic contribution to each sprint increases as RSA sets progress (Girard et al., 
2011). Therefore, aerobic capacity may become a limiting factor to RSA performance. 
Nevertheless, during a 6-second cycling sprint effort, anaerobic glycolysis and PCr degradation 
account for roughly 94% of total energy contribution (Spencer et al., 2005). The largest 
magnitude of change in average power output versus SHAM was after IPC in the current study, 
however the typical error was greater than the observed change of 12 watts, thereby leading us 
to conclude any improvement observed was “unclear”. Previous work suggests IPC 
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meaningfully enhances performance by approximately 1.5% in well-trained individuals 
(Ferreira et al., 2016), however the current enhancement versus SHAM was only 1.2%, possibly 
supporting the “unclear” inference. The trained cyclists in the current study were not track 
cyclists. Therefore, they were likely more aerobically trained versus other sprint-based athletes. 
Although further work is needed, IPC may become less effective in highly aerobic trained 
athletes (Hittinger et al., 2015) compared to recreationally active individuals (de Groot et al., 
2010). Whether training status influences the effects of IPC on performance remains 
undetermined. 
6.4.2 Effects of increasing muscle temperature 
Higher muscle temperatures when commencing exercise did not result in enhanced power 
output during the RSA task, as originally hypothesized. A 1°C elevation in muscle temperature 
previously enhanced cycling peak power by almost 10% (Faulkner et al., 2013a). Notably, the 
current study protocol employed a passive rest period of 14-minutes between the warm-up and 
RSA cycling, whereas the study of Faulkner et al. (Faulkner et al., 2013a) employed a 30-minute 
passive rest period. This longer rest duration could explain the variance in findings between 
theirs, and the present data set. This is discussed in more detail below in section 6.4.3. In addition 
to elevating muscle temperature, it is possible that passively maintaining core temperature with 
blizzard jackets in cool conditions could enhance sprint running performance in team sport 
athletes (Kilduff et al., 2013b). Importantly, studies using running as the primary sprinting 
modality, may be difficult to compare with cycling performance. Previous work documented 
greater sprint decrement scores (%) in cycling repeated sprint protocols versus running protocols 
(Girard et al., 2011). Therefore, comparisons between the two exercise modes may be difficult 
to interpret due to inducing different fatigue responses. The current findings suggest that after 
14-minutes of passive rest from a 19-minute incremental warm-up, consisting of sprint efforts, 
there is no need to passively maintain muscle temperature prior to performing 10x6-second 
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repeated sprints on a cycle ergometer. The warm-up protocol could be key to these findings and 
will be discussed in more detail below. 
6.4.3 Effects of combining interventions 
No benefit was observed after combining preconditioning strategies in the current study. The 
unclear change in performance between conditions may have partially been influenced by the 
choice of exercise bout. It is reported that intermittent tasks present lower inter-trial reliability 
when compared to fixed-end point, or constant load tasks (Hopkins, 2000). Regardless, the 
population used in the study were trained and showed good reliability before experimental trials 
commenced. Physiologically, it is unclear as to why no observed changes in either peak or 
average power were observed. It would be interesting to investigate whether a group of less-
trained individuals would benefit from the measured interventions, based on previously 
discussed findings (Hittinger et al., 2015).  
To expand upon a point raised in the previous section, the warm-up in the current study aimed 
to induce a potentiation response (Racinais et al., 2017) prior to the performance of RSA. Post-
activation potentiation (PAP) is a mechanism consistently shown to benefit high-intensity 
performance in athletes (Scott et al., 2016). Previous laboratory studies assessing the impact of 
either IPC or muscle heating interventions on anaerobic performance may have designed warm-
up protocols that lacked sufficient exercise intensity (Cruz et al., 2016), duration (Patterson et 
al., 2015) or enforced a rest period beyond optimal (Faulkner et al., 2013a). Previously, 
Faulkner et al. (Faulkner et al., 2013a) investigated muscle temperature elevations on sprint 
performance and conducted a warm-up involving 5-minutes of steady state cycling followed by 
5 x 10-second sprint efforts. The time between warm-up cessation and the sprint task was 
however 30-minutes, likely negating any warm-up potentiation effect (Rassier and Macintosh, 
2000). Additionally, Patterson et al. (Patterson et al., 2015) assessed the effect of IPC on RSA 
cycling and employed a 3-minute steady state cycling warm-up followed by 2 x maximal 6-
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second efforts. The rest period in this study (5-minutes) was much more optimal (Sargeant and 
Dolan, 1987), however, the duration of the warm-up itself was likely insufficient to induce 
sufficient elevations in muscle temperature (Racinais et al., 2017). The current study warm-up, 
lasting for 19-minutes in duration, was designed, based on how an athlete may try to optimise 
physiological readiness prior to competition (Bishop, 2003; Racinais et al., 2017). Therefore, 
the current findings of “unclear” changes after IPC versus SHAM, may imply that a sufficient 
warm-up stimulus negates the beneficial response of IPC during predominantly anaerobic 
exercise tasks. Future research should aim to explore anaerobic tasks that are preceded by more 
appropriate warm-up procedures.  
6.4.4 Muscle characteristics to RSA 
Muscle oxygenation kinetics are likely important in RSA, due to the previously highlighted 
aerobic component to performance (Girard et al., 2011). Although trends for enhanced muscle 
oxygenation responses were evident in heated conditions, “unclear” changes in power output 
were present. The impact of any changes at the muscular level were therefore likely insufficient 
to alter performance. Previously, it has been postulated that beneficial responses to IPC are 
induced via oxidative changes in the muscle. Based on the current evidence, during maximal 
repeated sprinting, any changes in muscle oxygenation are insufficient to exert meaningful 
responses on power production.  
When discussing muscle activity, there was no impact of EMG RMS (%) between conditions. 
Patterson et al. (2015) reported a possibly higher median frequency in EMG after IPC versus 
SHAM. In the current study, RMS was analysed to control for the differences in muscle 
temperature between preconditioning strategies. Greater muscle temperatures during exercise 
can alter neurophysiological excitatory during contractions (For review, see Racinais et al., 
2017). The current data suggest no changes in the reduction in muscle activity as sprint efforts 
progressed. 
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6.4.5 Limitations 
It is acknowledged that the largest limitation of this study is the sample size. The calculated 
typical error of the current task was 16 watts and 20 watts for average and peak power output, 
respectively but the small sample size likely made it difficult to accurately estimate changes in 
performance. However, it was previously shown that N=11 showed significant (9.6%) 
improvements in 30-second ‘all out’ sprint cycling with prior muscle heating, compared to a 
control (non-insulated) condition (Faulkner et al., 2013a). Their group showed no significant 
change compared between the muscle heating condition and an (non-heated) insulated condition 
in that study (Faulkner et al., 2013a). In the current study, all cyclists wore bib shorts during 
heated and T-N conditions, whilst elasticated tubigrips were used in T-N conditions to support 
and fix NIRS and EMG units. This may have acted as minor insulation in the T-N condition in 
the present study, but whether this explains the lack of significant differences between muscle 
temperature groups remains unknown. For sprint tasks, constant speed/power or duration tasks 
may provide better signal:noise ratios compared with intermittent protocols (Hopkins, 2000). 
Assessment of this type of performance task may allow more accurate determination of the 
impact of IPC or muscle heating on anaerobic performance. The major methodological 
limitation was muscle temperature was not directly measured in the current study. Nevertheless, 
validation of muscle heating methods was performed in a small number of participants to show 
muscle temperatures increased by 1°C at the start of sprinting, compared to thermo-neutral 
conditions. Additionally, this study documented skin temperature which also demonstrated clear 
differences between heated and T-N preconditioning strategies. 
6.4.6 Conclusion 
The current data suggest for the first time that RSA is unlikely further enhanced by 
implementing the “traditional” IPC dose, passively heating muscles to maintain post warm up 
temperature, or combining both strategies together when compared to a SHAM condition. 
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Moreover, it does not seem that IPC can enhance RSA cycling, regardless of whether 
implemented with thermoneutral or elevated muscle temperatures. This may provide greater 
clarity on the efficacy of IPC when integrated and compared with other popular preconditioning 
strategies. 
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Chapter 7 
Thesis Synthesis 
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7.1 Major Findings 
The major findings from this thesis are: 
1. When comparing the different IPC “doses” employed in the current thesis, the 
“traditional” 4x5-min IPC protocol may result induce preferential aerobic exercise 
performance. 
2. Remote or local cuff placement mediates similar performance and blood flow responses 
to exercise.  
3. Local “traditional” IPC enhances torque production before and after EIMD  
4. Local “traditional” IPC does not impact cycling repeated sprint ability performance.  
5. The combination of local “traditional” IPC and increasing muscle temperature does not 
enhance repeated sprint performance improvements. 
7.2 General discussion of findings 
Many of the >40 investigations that are published on IPC and exercise at the time of writing this 
work, have employed different methodological approaches of how IPC is performed. Chapter 3 
of this thesis highlights that the “traditional” 4x5 mins cycles may provide the most benefit to 
exercise performance. The occlusion of two limbs seems to be more effective than occluding 
just one limb and Remote or local cuff placement leads to similar performance outcomes. A 
linear dose-response to IPC is not present, with a greater number (8x5-minute) of cycles 
providing no additional benefit to a “traditional” 4x5-minute protocol. Importantly, a greater 
number of cycles was not harmful to performance which may be important finding when 
discussing ‘hyperconditioning’ with ischaemia. The importance of utilising “low-dose” 
ischaemic conditioning in clinical patients has previously been highlighted, following 
observations that 12x ischaemia-reperfusion cycles may induce deleterious collagen responses 
in the myocardium (Whittaker et al., 1991; Whittaker and Przyklenk, 2014). The findings of the 
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current thesis highlight that employment of more (8x) ischaemia-reperfusion cycles is not 
damaging to exercise performance versus SHAM. Importantly, however, because no benefit is 
observed versus the “traditional” 4x5-minute IPC dose, no further cycles should be employed 
beyond four, prior to exercise. This is an important protocol finding for athletes contemplating 
the use of IPC prior to performance (Figure 7.1). 
What are the underlying mechanisms explaining exercise benefits of IPC? 
It is previously shown that IPC alters neuromuscular (Cruz et al., 2015) and/or cardiovascular 
(Bailey et al., 2012) function during or after exercise, respectively. The work in chapter 4 of 
this thesis assessed conduit artery responses during and following submaximal exercise. The 
findings of greater conduit artery dilation after local versus Remote IPC during submaximal 
handgrip exercise are novel. To date, study designs investigating vascular responses to IPC, 
either at rest (Enko et al., 2011) or during exercise (Barbosa et al., 2015) have not compared the 
location of cuff placement on vascular responses. Previous work investigating macrovascular 
responses during exercise has only been performed in a severe-domain intensity handgrip task 
to exhaustion (Barbosa et al., 2015). The rationale for investigating submaximal exercise blood 
flow and vascular function responses was to try to establish a mechanistic link to further 
investigate how IPC can impact aerobic exercise performance (Salvador et al., 2016). 
Conduit artery responses to exercise were assessed, via ultrasound measurement, a technique 
deemed suitable for assessment of vascular function (Woodman et al., 2001). During exercise, 
ultrasound measurement requires minimal limb movement to optimise artery image and enhance 
recording signal. Fixed angle, small muscle mass exercise tasks are therefore chosen to 
maximise the validity and reliability of measurements obtained. Nevertheless, the nature of 
small-muscle mass exercise e.g. handgrip exercise, is not representative of most athletic tasks. 
Only ‘whole-body’ exercise models can truly account for blood flow and vascular changes that 
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take place during hard exercise bouts, such as: 1) greater lower limb perfusion pressures (Joyner 
and Casey, 2015); 2) respiratory muscle blood flow demand and fatigue that competes with (or 
compromises) limb blood flow (Romer and Polkey, 2008); and 3) direct vascular responses such 
as metabo-reflex induced vasoconstriction (Romer and Polkey, 2008). Under whole-body 
exercise conditions, the conduit artery response to exercise would likely change. Development 
of methods to accurately measure blood flow changes during more intense ‘whole-body’ 
exercise tasks, will ultimately be needed to test the efficacy and validity of the findings in 
chapter 4 of this thesis.  
No improvement in post-exercise vascular function was observed in chapter 4 between 
conditions. Previously, IPC improved post-exercise vascular function in the inactive (arm) limb 
versus a SHAM condition following 5-km running TT performance (Bailey et al., 2012). The 
reduction in FMD in inactive limbs after strenuous exercise may be resultant from circulatory 
increases in active substances such as reactive oxygen species (ROS) (Taniyama and Griendling, 
2003; Weseler and Bast, 2010). FMD assessments in chapter 4 of this thesis were performed on 
the exercising limb, unlike the study of Bailey et al. (Bailey et al., 2012). It may be that active 
(exercising) limbs experience increases in arterial pressures, potentially inhibiting eNOS 
production via reduced sympathetic outflow (Green et al., 2004). Inactive limbs however, may 
experience reductions in vasodilatory function, through other mechanisms, such as exposure to 
factors such as circulatory ROS. Although speculative, it may be postulated that IPC could offer 
“limb specific” systemic protection against circulatory ROS in inactive limbs, thereby 
improving FMD in inactive limbs. 
Can IPC prevent exercise-induced muscle damage in response to strenuous exercise? 
Chapter 5 expanded on the preliminary findings that IPC can positively influence muscle 
damage responses in humans (Franz et al., 2017a) and also validated the rationale to use a 4x5-
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minute “traditional” IPC dose prior to muscle damaging exercise. The findings of this chapter 
observed no changes in muscle torque recovery kinetics versus SHAM, a finding that contradicts 
previous work assessing the application of post EIMD intermittent occlusion bouts (Beaven et 
al., 2012; Page et al., 2017). Therefore, it remains unclear whether IPC specifically protects 
against muscle damage, or simply enhances exercise performance via a “delayed 
preconditioning” response, independent of EIMD.  
The work of chapters 3 and 4 of this thesis directed and informed the implementation of what 
was perceived to be the “preferred” IPC protocol prior to exercise. Muscle damaging (eccentric) 
exercise is inherently different to a concentrically dominated performance task (Franz et al., 
2017b) and induces different contractile demands  during an exercise bout (Asp et al., 1998). 
Currently, there is no evidence to suggest that a more rigorous (greater amount of cycles / 
occlusion mass / repeated daily IPC) would induce different tissue-protective responses to the 
“traditional” dose of IPC that was employed. However, it could be speculated that the damaging 
nature of eccentric contractions could benefit from a greater priming (IPC) response and this is 
something that may deserve future research attention. Currently, the infancy of this research 
would infer that team sport, or competition setting athletes, that play on consecutive days, could 
benefit from this intervention. This is discussed in more depth in section 7.3. 
Does IPC lose potency when combined with other “beneficial” strategies? 
Both central and peripheral fatigue are limiting to repeated sprint exercise performance 
(Racinais et al., 2007). Chapter 6 was only able to investigate a limited number of variables that 
potentially contribute to augmentation of repeated sprinting (Bishop et al., 2011; Girard et al., 
2011). In an applied setting, the exposure to more external variables may further influence 
performance capability. One example of an introductory external variable when moving from 
the laboratory setting, to an applied setting may be the use of ergogenic aids (e.g. caffeine) prior 
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to exercise. Caffeine is a frequently used substance by athletes (Goldstein et al., 2010) and the 
ability of caffeine to enhance performance is well documented (Goldstein et al., 2010). It is not 
necessarily caffeine’s ability to enhance performance, but instead, the physiological action of 
caffeine that is important to consider when applying IPC prior to exercise. IPC directly acts on 
the adenosine pathway (specifically acting on A1 and A3 receptor agonists) (Riksen et al., 2004), 
whilst caffeine is a potent adenosine antagonist (Smits et al., 1990, 1987), with a high affinity 
to adenosine (A1 and A2A) binding sites (Huang et al., 2005). This competitive binding action 
on adenosine receptors may explain abolished tissue protection following IPC when caffeine is 
administered (Riksen et al., 2006). Additionally, other vasodilatory substances, capable of 
enhancing exercise capacity, such as dietary nitrates (Bailey et al., 2010), have been shown to 
be ineffective when combined with or compared to traditional caffeine supplementation 
(Glaister et al., 2015).  Practically, unless athletes are caffeine intolerant or chose not to take 
caffeine for personal reasons, the efficacy of IPC to benefit the elite or competitive sports person 
may well be limited unless this work is undertaken to show otherwise. Advances in this research 
field are necessary for IPC to be proven efficacious in elite settings. This concept expands 
through all related chapters of this thesis, as ultimately, each chapter was designed to provide 
some inference into an area of exercise performance with the aim of eventually transitioning 
toward the elite performer.  
Elite performers are also known to optimise warm-up strategies. It is possible, that warm-up 
protocols may influence the potency of IPC on subsequent anaerobic exercise tasks for reasons 
discussed in section 6.4.3. Whilst the warm-up was sufficient for chapter 3, the aim was not to 
induce a potentiation on the muscle, as this has only shown to benefit maximal (anaerobic) 
performance tasks (Racinais et al., 2017). If the SHAM condition RSA task was afforded a 
potentiating response from warming up optimally in the work of chapter 6, this would again 
raise questions toward the efficacy of using IPC in elite sport, where warm-up procedures are 
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often optimised. Presently, several studies documenting benefits of IPC may have implemented 
sub-optimal warm-ups. Such a simple methodological consideration may be of vital importance 
in determining the efficacy of IPC in elite sport.  
Does exercise mode matter? 
Whilst physiological fatigue mechanisms were not directly measured, IPC has been suggested 
to enhance central motor drive (Cruz et al., 2015), via a IPC-induced blunting of group III and 
IV afferent feedback (Crisafulli et al., 2011). Group III and IV afferents respond to exercise-
induced metabolite accumulation in the interstitial space (Burnley and Jones, 2018), and their 
activation/firing are thought to limit capacity during severe, or extreme domain exercise (Amann 
et al., 2015). The action of IPC on these afferents has been widely discussed (Angius et al., 
2017; Cruz et al., 2017) and if enhancement of central motor drive is key to the improvement 
of supramaximal performance, an exercise task that does not allow recovery (even incomplete 
recovery) between efforts, may better elucidate mechanisms that contribute to enhancements in 
supramaximal exercise capacity. It may therefore be interesting to determine the impact of IPC 
on fixed-end point or constant duration extreme-domain exercise bouts that do not allow 
(partial) recovery throughout the effort. 
7.3 Practical implications for athletes 
Presently, it appears that employment of a 4x5-minute “traditional” protocol on the working 
musculature elicits the greatest physiological responses during exercise, as determined from the 
work in this thesis.  
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Figure 7. 1. A schematic representation of the optimal protocol for athletes to employ IPC as a 
pre-exercise strategy based on the current research evidence and the findings from this thesis. 
 
A “traditional” IPC protocol applied locally to the working limbs may provide benefit to 
endurance TT performance in trained cyclists (figure 7.1), however testing IPC in elite athletes, 
alongside the consumption or use of other pre-race (nutritional) ergogenic strategies (such as 
caffeine) is needed to determine whether beneficial findings of IPC are ecologically valid. 
Importantly, in addition to the wealth of research on the potential impact of IPC to enhance 
exercise performance, this thesis contributed to the field of muscle damage, with the suggestion 
that IPC may also prevent a decline in exercise performance typically experienced from EIMD. 
Indeed, the promising findings in chapter 5 suggests that development of future studies assessing 
the EIMD responses to IPC, in more applied sporting settings, may be warranted. Presently, 
there is no sport specific data to suggest IPC could benefit force production or exercise capacity 
during competition settings. Currently these data do not present sufficient evidence for IPC to 
be used by athletes. When postulating the long-term application of using IPC to prevent 
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deleterious effects of muscle damage, tournament settings could be an ideal target. Tournament 
settings are often characterized by playing numerous games or competing in several events in a 
short period of time. The caveat to condensed sporting schedules is an inability to recovery 
physically between games/competition, especially if competition is comprised of numerous 
eccentric or deceleration loading tasks. The work contained in this thesis provides rationale to 
expand and develop understanding of both the muscle (mechanical) and systemic (biomarker) 
responses to IPC when more tournament sports-specific tasks are performed. Many team sport 
events often contain numerous deceleration or eccentrically loaded movements (Russell et al., 
2016), sometimes even repetitive player contacts (Singh et al., 2011) that can lead to muscle 
damage, alongside reductions in muscle function in subsequent days that follow competition 
(Ascensão et al., 2008).  
7.4 Recommendations for future work 
1. Is there a ‘minimal effective’ dose of IPC? 
Coaches and athletes are often time-restricted prior to competitive events, therefore, any finding 
of a ‘minimal effective dose’, would be highly impactful when aiming to employ IPC in an 
applied setting. The 3x5-minute IPC protocol, as first assessed in the seminal IPC and exercise 
study (de Groot et al., 2010) has shown to be effective in a range of tasks. Additionally, 
enhanced recovery from exercise was observed following 2 x 3-minute occlusion cycles 
(Beaven et al., 2012). A direct comparison of shorter protocols when compared to the 4x5-
minute local IPC protocol used throughout this thesis may be warranted to establish whether a 
more time-effective IPC strategy exists.  
2. Is there a mechanistic response to delayed IPC? 
This thesis did not focus on the application of delayed (approx. 24 hours prior to exercise) IPC, 
which also may provide a time benefit to the competing athlete (Seeger et al., 2016). The impact 
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and effectiveness of delayed IPC remains unclear and has only been investigated using 
performance tasks (Seeger et al., 2016). New mechanistic work has recently been published, 
showing red blood cell deformability can potentially establish IPC responders (Tomschi et al., 
2018). A technique such as this could be utilised within this type of study. Additionally, 
investigation into other physiological mechanisms, such as vascular responses during exercise 
may provide better insight into whether delayed IPC is a strategy worth pursuing for the athlete. 
This may help to establish whether, as previously proposed (Seeger et al., 2016), participants 
may be “responders” to IPC, regardless of timing. 
3. Can IPC alter vascular responses to whole body exercise? 
Increasing the amount of working musculature, alters the limb blood flow demand of skeletal 
muscle, as previously discussed in this chapter. Additionally, more intense ‘whole-body’ 
exercise may alter the vasodilatory responses to an exercise task (Romer and Polkey, 2008). To 
truly determine the impact IPC may have during intense exercise, conduit artery measurement 
should ideally be established during a whole-body exercise task, across a range of intensities. 
The replication of a similar study design to chapter 4, involving higher intensity, lower limb bi-
lateral isometric contractions may allow for accurate ultrasound measurement and provide a 
greater understanding and/or validation of the current thesis findings relating to conduit artery 
function. 
4. Can IPC enhance simulated team sport performance in athletes experiencing eccentric-
exercise induced muscle damage?  
The work in this thesis currently demonstrates that IPC enhances maximal torque production 
before and after EIMD. To better apply these findings to athletes, further investigation of a 
controlled exercise task, representative of team sport competition demands, is needed. Using a 
similar design to chapter 5, a simulated soccer protocol could be employed using a non-
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motorized treadmill (Aldous et al., 2014). The protocol could be performed on a baseline (pre-
ECC) visit and then at 24- and 72-hrs after eccentric exercise (EIMD) has occurred. Blood 
markers could also be taken to further investigate systemic extracellular stress responses to 
exercise, expanding on work performed in the current thesis. This research would develop a 
better practical understanding of whether IPC could meaningfully benefit team sport athletes 
that experience muscle damage in tournament-style settings. 
5. Can exercise preconditioning reduce the impact of IPC on anaerobic performance? 
If the eventual aim of IPC research is to inform athletic practice, future studies should aim to 
replicate applied practice more accurately. A simple example of this, is by using more 
appropriate warm-ups prior to laboratory tasks. Not only can exercise alone be a preconditioning 
stimulus in a similar manner to IPC (Crisafulli et al., 2007), performing a suitable warm-up can 
induce a potentiating response during high-intensity (anaerobic) exercise performance. 
Currently, most studies showing benefit to IPC in anaerobic tasks, have failed to employ 
“optimal” warm-up protocols. Whether IPC would augment anaerobic performance if exercise 
was potentiated naturally (via an optimised warm-up) remains unclear. This research may again 
lead to better understanding of how effective IPC may be in elite settings. 
6. Would a combined ‘warm-up’ strategy provide larger performance benefits on constant 
load or constant duration anaerobic tasks? 
Elevated muscle temperature can be ergogenic to anaerobic, power-based exercise tasks 
(Faulkner et al., 2013b) if a sufficient rest time is undertaken between the warm-up and exercise 
bout. Based on the suggestion that IPC could potentiate anaerobic metabolism (Paradis-
Deschênes et al., 2016) a similar study design to chapter 6, prior to an “all out” one-off maximal 
task may provide greater clarification as to whether this practical preconditioning model can 
enhance anaerobic performance. Additionally, it is plausible that longer duration maximal 
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efforts may be a more appropriate exercise task to further investigate central motor drive 
responses to IPC. Importantly, many of the studies on IPC to date have relatively small sample 
sizes. It may therefore be more appropriate to assess the impacts on sprint performance by using 
tasks shown to reduce the noise of a test (improving the signal:noise ratio) (Hopkins, 2000). 
7. What are the vascular and performance responses to IPC and caffeine in trained 
individuals? 
Currently, IPC has not been implemented with “elites” in applied settings. If the eventual goal 
is to develop this strategy in elite performers, it needs to be first tested in ecologically valid 
settings, which may include the use of ergogenic aids such as caffeine. The ergogenic response 
to caffeine is widely published (Goldstein et al., 2010) and it is highly popular substance among 
athletes, since its re-instatement by the world anti-doping agency (WADA). For IPC to be 
considered worthwhile in athletes that consume caffeine, a range of performance tasks that are 
undertaken with either caffeine, versus or in combination with IPC, should be performed. A 
replication of a model similar to that employed by Bailey et al. (2012) whereby vascular function 
assessments are performed pre- and post-severe domain exercise could be insightful at both a 
performance and mechanistic level. The performance of an exercise task that elicits (near to) 
?̇?O2max may be optimal for this type of study. This advance in research direction is vital for IPC 
to (if ever) be considered on the elite stage. 
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